Cargando…
Cross-Sectional Exploration of Plasma Biomarkers of Alzheimer’s Disease in Down Syndrome: Early Data from the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) Study
With improved healthcare, the Down syndrome (DS) population is both growing and aging rapidly. However, with longevity comes a very high risk of Alzheimer’s disease (AD). The LIFE-DSR study (NCT04149197) is a longitudinal natural history study recruiting 270 adults with DS over the age of 25. The st...
Ejemplares similares
-
Development of a symptom menu to facilitate Goal Attainment Scaling in adults with Down syndrome-associated Alzheimer’s disease: a qualitative study to identify meaningful symptoms
por: Knox, Kari, et al.
Publicado: (2021) -
Medicaid Enrollment and Service Use Among Adults With Down Syndrome
por: Rubenstein, Eric, et al.
Publicado: (2023) -
Epileptic spasms in individuals with Down syndrome: A review of the current literature
por: Kats, Daniel J., et al.
Publicado: (2020) -
Down Syndrome: Neuropsychological Phenotype across the Lifespan
por: Pulsifer, Margaret
Publicado: (2021) -
Opportunities, barriers, and recommendations in down syndrome research
por: Hendrix, James A., et al.
Publicado: (2021)